Annual screening is covered for patients without symptoms of lung cancer aged 55-77 years who have a tobacco smoking history of at least 30 pack-years and who are either currently smoking or have quit in the past 15 years. If you do not meet this criteria, but are still interested in a screening, please call 973-426-6444 to discuss your options.
The number of years of smoking is multiplied by number of packs smoked daily. For instance, someone who smokes 1 pack a year for 30 years has a smoking history of 30 pack-years, or smokes 2 packs a year for 15 years also has a smoking history of 30 pack years.
Patients who fall outside of eligibility for Lung Cancer Screening program but have lung nodules previously detected on imagining tests can participate in Lung Nodule Program.
No. Although most of our patients are referred by their doctors, patients can self-refer themselves or refer a friend or a relative for screening.
Patients can call (973) 429-6444 to reach a Nurse Navigator Linda West for Lung Cancer Screening and Lung Nodule Program, who will ask a few questions to assess eligibility and schedule a screening appointment.
On the day of the appointment, patient will have a 30 minutes interview and physical exam with Physician Assistant Valentina Kolker to be enrolled into the program.
After the interview, the patient is escorted for Low Density CT scan.
Official Radiologist reading is available the next day. Patient will be notified the following day over the phone by the Physician Assistant. All screening scans are reviewed by a Lung Cancer Team, including pulmonologist, radiologist and thoracic surgical oncologist.
Screening will provide:
Our Lung Center brings together a dedicated team that includes thoracic surgeons, pulmonologists, thoracic radiologists, oncologists and pathologists to provide patients with advanced care.
In the event of finding a cancer, the Hackensack Meridian Mountainside Medical Center, a comprehensive program accredited with commendation by the Commission on Cancer, can provide a caliber of care that’s unsurpassed at any other hospital. Our multidisciplinary team works collaboratively to ensure that every patient receives “whole person” care that addresses all physical, emotional and practical needs and achieves the very best outcome.
SuperDimension™ LungGPS™ - When a nodule that requires further investigation is found on a scan, rather than a traditional biopsy, our specially trained doctors will use the SuperDimension™ system, unique state-of-the-art technology that affords greater diagnostic clarity and reduces a patient’s risk of complications and discomfort. SuperDimension™ - also known as LungGPS™ - allows physicians to more precisely locate nodules even when they are in deep, hard to reach areas of the lungs by performing a minimally invasive procedure called an Electromagnetic Navigation Bronchoscopy™ or ENB.
EBUS (Endobronchial Ultrasound) - a type of bronchoscopy device that incorporates flexible bronchoscope with build-in ultrasound probe. EBUS allows for biopsy of the lymph nodes in the chest and surrounding tissue without a surgery. It provides minimally invasive way to asses if the cancer has spread outside of the lung. . Having this advanced technology on site at Hackensack Meridian Mountainside Medical Center enables us to arrive at a staging and treatment plan faster, with greater accuracy and less risk and radiation exposure to the patient.
CT Guided Biopsy – Highly trained Interventional Radiologists can sample nodules using CAT scanners to define whether nodules are cancerous or not, as well as often clarify their genetic behavior to guide therapy.
Lopa Patel, M.D., FCCP
Medical Director of Lun Cancer/Lung Screening Program
Dr. Patel is a board certified pulmonologist and Sleep Medicine Specialist, and is currently the director of the division of pulmonary medicine. Dr. Patel has been practicing since 2005, after she received her medical education from the Ross University School of Medicine and completed her internal medicine residency at Newark Beth Israel Medical Center.
Nazly M. Shariati, M.D.
Medical Director of Thoracic Surgery and Surgical Director of the Lung Cancer Screening/Lung Nodule Program
Dr. Shariati is a board-certified thoracic and general surgeon specializing in lung surgery, lung acncer, thoracic surgery, tracheal surgery and esophageal cancer. She earned her medical degree from the University of Cincinnati and completed a residency in general surgery at Morristown Memorial Hospital. Following her general surgery residency, she completed a cardiothoracic surgery fellowship at Montefiore Medical Center in the Bronx, New York and a lung transplant fellowship at the University of Pittsburgh Medical Center. Dr. Shariati has been serves on several nationally recognized boards and committees and has been named one of Castle Connolly’s top doctors for cardiothoracic surgery.